Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
KIWA BIO-TECH PRODUCTS GROUP CORP
| Metric | KIWA BIO-TECH PRODUCTS GROUP CORP Materials |
|---|---|
| Quality Score | 52 / 100 |
| Revenue (latest) | $40M |
| Net income (latest) | −$7M |
| Operating margin | −3.0% |
| Net margin | −16.6% |
| Return on equity | −68.5% |
| Return on assets | −27.6% |
| Return on capital (ROCE) | −12.1% |
| Debt / equity | 1.49× |
| Revenue growth (YoY) | 30.8% |
| Altman Z″ (distress) | -0.15 |
| Accruals / assets | −28.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.